Objective
Aspects of mouse genetics which are of strategic importance for the progress of human genome analysis were studied. This covered 3 important areas:
Detection and molecular analysis of mutations which serve as models for human genetic disease, using several mutagenesis protocols. A large number of disease genes have been detected, mapped and are being further used for study of the genetic nature and functional mechanisms of the defects. An invaluable collection of mutant mouse stocks have been created in the cryopreservation project at the MRC Radiobiology Unit.
Detection, mapping and analysis of genes controlling predisposition to multigenically controlled diseases. This is a novel area of mouse genetics, concentrating on mouse models for the most common human diseases such as cancer, cardiovascular and metabolic diseases, which form a major proportion of morbidity and mortality. Although it is recognized that the development of these diseases is under strong genetic influence, it is extremely difficult to identify the relevant genes in humans. A novel genetic tool, the recombinant congenic strains method has been developed and successfully applied to the study of the genetics of colon cancer, atherosclerosis, and immune response, indicating that this broad area of genetics is open for efficient investigation.
An increasingly important area of genome analysis uses germ line modification (transgenesis, homologous recombination) through which specific genes can be added to, or deleted from, the genome. A number of methodological and conceptual contributions has been made to this area, increasing the effectiveness of the methodology and applying it successfully to gens involved in lymphoma development. The improvement of the methods of homologous recombination is of great general value to the broad application of this technology. The use of transgenic mice in combination with retroviral induction of lymphomas paved the way to identification of several novel oncogenes and definition of complementation groups of oncogenes in lymphomagenesis, which provides new insights into the molecular alterations during lymphomagenesis. This approach can serve as a general model for a more efficient analysis of the genetic alterations during tumorigenesis.
Recent advances in mutagenesis and genetic mapping, particularly in European laboratories, now make possible detailed genome analysis of the mouse, the genetically best known vertebrate. The three Institutes propose a joint effort to this end, using advanced genetic and molecular teechniques, with emphasis on the genes relevant for tumor and disease susceptibility and development, and their human homologues, and on genetic models for human disease. The specific tools developed in individual Institutes for identification and mapping of genes, namely mutant stocks, recombinant congenic strains, and interspecific backcrosses, complement each other and will also be used to correlate physical maps with linkage maps. The identified genes will be cloned and analysed for their function using transgenic mice and mutagenesis by homologous recombination.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- social sciences sociology demography mortality
- medical and health sciences clinical medicine cardiology cardiovascular diseases arteriosclerosis
- medical and health sciences basic medicine immunology
- medical and health sciences clinical medicine oncology colorectal cancer
- natural sciences biological sciences genetics genomes
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
1066 CX AMSTERDAM
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.